Clinical Trials Browser

Phase 2 × Metastatic Pancreatic Adenocarcinoma × Taxes × Clear all

NCT06576115 2025-11-05

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma